ask="0.71"
ask_size="6000"
average_daily_volume="130892"
bid="N/A"
bid_size="N/A"
book_value="0.73"
change="-0.02"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="-0.49"
change_from_52_week_high="-1.37"
change_From_52_week_low="0.03"
change_in_percent="-2.40%"
close="0.63"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.81"
ebitda="-30.60M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.86"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.63"
high_52_weeks="2.00"
last_trade_date="2/24/2017"
last_trade_price="0.63"
last_trade_size="218"
last_trade_time="4:00pm"
low="0.60"
low_52_weeks="0.60"
market_capitalization="24.35M"
moving_average_200_day="1.34"
moving_average_50_day="1.12"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="0.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-53.07%"
percent_change_from_50_day_moving_average="-43.66%"
percent_change_from_52_week_high="-68.50%"
percent_change_from_52_week_low="+5.00%"
previous_close="0.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.89"
price_per_sales="2.55"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.37"
stock_exchange="NMS"
symbol="AVIR"
volume="39909"
weeks_range_52="0.60 - 2.00"
